Latest News
UK-based tuberculosis treatment trial recruits first participant
The RID-TB: Treat trial, which will assess two newly-shortened treatment regimens along with additional treatment support, recruited its first participant last week at the Royal Free Hospital in London.
Which people with metastatic prostate cancer benefit most from upfront docetaxel?
STOPCAP M1 meta-analysis reveals that the benefits of docetaxel vary depending on some characteristics of the prostate cancer.
New podcast episode: How can clinical trials make the most of healthcare systems data?
In the latest Trial Talk episode, we explore the opportunities and challenges of using data from healthcare systems in clinical trials.
Could long-acting injectable medicines replace daily HIV tablets in young people living with HIV in Africa?
A new clinical trial will test whether long-acting injectable HIV medicines, given every eight weeks, work as well as daily tablets to keep the virus under control.
Global study highlights deaths from neonatal sepsis and urgent need to improve treatment
The NeoOBS global observational study has shown that a growing number of newborns are dying because the antibiotics used to treat sepsis are becoming ineffective.